KRT80 and neoplasm: In addition, KRT80 can distinguish CRC tumors from normal tissues and the phenotype of MSS from MS‐H, which is associated with the tumor microenvironment and the efficacy of immune checkpoint therapy in CRC, making KRT80 a potentially important biomarker for CRC.27